Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

Safe Administration of Electroconvulsive Therapy in a Patient With Catatonia and Neuropsychiatric Lupus Comorbid With Fragile X Syndrome.

Subjects: Catatonia*/Catatonia*/Catatonia*/complications ; Catatonia*/Catatonia*/Catatonia*/therapy ; Electroconvulsive Therapy*

  • Source: The journal of ECT [J ECT] 2022 Dec 01; Vol. 38 (4), pp. 258-260. Date of Electronic Publication: 2022 May 05.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9808943 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Central Nervous System Trial Failures: Using the Fragile X Syndrome-mGluR5 Drug Target to Highlight the Complexities of Translating Preclinical Discoveries Into Human Trials.

  • Authors : Grabb MC; From the National Institute of Mental Health, NIH Rockville, MD.; Potter WZ

Subjects: Fragile X Syndrome*/Fragile X Syndrome*/Fragile X Syndrome*/drug therapy; Brain ; Central Nervous System

  • Source: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2022 May-Jun 01; Vol. 42 (3), pp. 234-237.Publisher: Williams And Wilkins Country of Publication: United States NLM ID: 8109496 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Fragile X syndrome: an update on developing treatment modalities.

  • Authors : Healy A; Seaside Therapeutics, 840 Memorial Drive, Cambridge, Masssachusetts 02139, USA.; Rush R

Subjects: Central Nervous System Agents/Central Nervous System Agents/Central Nervous System Agents/*chemistry ; Central Nervous System Agents/Central Nervous System Agents/Central Nervous System Agents/*therapeutic use ; Drug Discovery/Drug Discovery/Drug Discovery/*trends

  • Source: ACS chemical neuroscience [ACS Chem Neurosci] 2011 Aug 17; Vol. 2 (8), pp. 402-10. Date of Electronic Publication: 2011 Mar 22.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101525337 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Burden of illness among patients with fragile X syndrome (FXS): a Medicaid perspective.

  • Authors : Nazareth T; a a Novartis Pharmaceuticals Corporation , East Hanover , NJ , USA.; Li N

Subjects: Cost of Illness* ; Health Care Costs*; Fragile X Syndrome/Fragile X Syndrome/Fragile X Syndrome/*economics

  • Source: Current medical research and opinion [Curr Med Res Opin] 2016; Vol. 32 (3), pp. 405-16. Date of Electronic Publication: 2015 Dec 23.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Fragile X syndrome and targeted treatment trials.

  • Authors : Hagerman R; Department of Pediatrics, University of California, Sacramento, CA, USA. ; Lauterborn J

Subjects: Fragile X Syndrome/Fragile X Syndrome/Fragile X Syndrome/*drug therapy; Animals ; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/therapeutic use

  • Source: Results and problems in cell differentiation [Results Probl Cell Differ] 2012; Vol. 54, pp. 297-335.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0173555 Publication Model: Print Cited Medium: Print ISSN: 0080-1844 (Print)

Record details

×
Academic Journal

[Advances in treatment of fragile X syndrome].

  • Authors : Lisik M; Katedra i Zakład Biologii Ogólnej, Molekularnej i Genetyki, Śląski Uniwersytet Medyczny, ul. Medyków 18, 42-583 Katowice. ; Sieroń A

Subjects: Central Nervous System Stimulants/Central Nervous System Stimulants/Central Nervous System Stimulants/*therapeutic use ; Fragile X Syndrome/Fragile X Syndrome/Fragile X Syndrome/*diagnosis ; Fragile X Syndrome/Fragile X Syndrome/Fragile X Syndrome/*drug therapy

  • Source: Neurologia i neurochirurgia polska [Neurol Neurochir Pol] 2010 Sep-Oct; Vol. 44 (5), pp. 504-10.Publisher: Via Medica Country of Publication: Poland NLM ID: 0101265 Publication Model: Print Cited Medium: Print ISSN: 0028-3843 (Print)

Record details

×
Academic Journal

The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome.

  • Authors : Wirojanan J; Medical Investigation of Neurodevelopmental Disorders (M.I.N.D.) Institute, University of California Davis Health System, Sacramento, CA 95817, USA.; Jacquemont S

Subjects: Autistic Disorder/Autistic Disorder/Autistic Disorder/*complications ; Central Nervous System Depressants/Central Nervous System Depressants/Central Nervous System Depressants/*therapeutic use ; Fragile X Syndrome/Fragile X Syndrome/Fragile X Syndrome/*complications

  • Source: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine [J Clin Sleep Med] 2009 Apr 15; Vol. 5 (2), pp. 145-50.Publisher: American Academy of Sleep Medicine Country of Publication: United States NLM ID: 101231977 Publication Model: Print Cited Medium: Print

Record details

×
  • 1-10 of  474 results for ""Central Nervous System""